Final  	Final  	 JJ	B-NP
report  	report  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
safety  	safety  	 NN	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
Piper  	Piper  	 NNP	B-NP
methysticum  	methysticum  	 FW	I-NP
leaf 	leaf 	 FW	I-NP
/ 	/ 	 FW	I-NP
root 	root 	 FW	I-NP
/ 	/ 	 FW	I-NP
stem  	stem  	 FW	I-NP
extract  	extract  	 FW	I-NP
and  	and  	 CC	O
Piper  	Piper  	 NNP	B-NP
methysticum  	methysticum  	 FW	I-NP
root  	root  	 FW	I-NP
extract  	extract  	 FW	I-NP
Piper  	Piper  	 FW	I-NP
methysticum  	methysticum  	 FW	I-NP
leaf 	leaf 	 FW	I-NP
/ 	/ 	 FW	I-NP
root 	root 	 FW	I-NP
/ 	/ 	 FW	I-NP
stem  	stem  	 FW	I-NP
extract  	extract  	 FW	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
cosmetic  	cosmetic  	 JJ	B-NP
ingredient  	ingredient  	 NN	I-NP
name  	name  	 NN	I-NP
for  	for  	 IN	O
a  	a  	 DT	O
material  	material  	 NN	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
leaves 	leaves 	 NNS	O
,  	,  	 ,	O
roots 	roots 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
stems  	stems  	 VBZ	O
of  	of  	 IN	O
the  	the  	 DT	O
Piper  	Piper  	 NNP	O
methysticum  	methysticum  	 VBD	O
G.  	G.  	 NNP	B-NP
Forster  	Forster  	 NNP	I-NP
plant 	plant 	 NN	I-NP
,  	,  	 ,	O
commonly  	commonly  	 RB	O
known  	known  	 VBN	O
as  	as  	 IN	O
kava  	kava  	 JJ	O
kava 	kava 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
and  	and  	 CC	O
other  	other  	 JJ	O
kava-derived  	kava-derived  	 JJ	O
ingredients  	ingredients  	 NNS	O
are  	are  	 VBP	O
used  	used  	 VBN	O
as  	as  	 IN	O
skin-conditioning  	skin-conditioning  	 JJ	O
agents  	agents  	 NNS	O
at  	at  	 IN	O
concentrations  	concentrations  	 NNS	B-NP
from  	from  	 IN	O
0.0001 	0.0001 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
0.1 	0.1 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
Food  	Food  	 NNP	O
and  	and  	 CC	O
Drug  	Drug  	 NNP	B-NP
Administration  	Administration  	 NNP	I-NP
issued  	issued  	 VBD	O
a  	a  	 DT	O
consumer  	consumer  	 NN	O
advisory  	advisory  	 NN	B-NP
in  	in  	 IN	O
2002  	2002  	 CD	O
expressing  	expressing  	 JJ	O
concern  	concern  	 NN	O
about  	about  	 IN	O
liver  	liver  	 JJ	O
damage  	damage  	 NN	O
in  	in  	 IN	O
individuals  	individuals  	 NNS	O
who  	who  	 WP	O
have  	have  	 VBP	O
ingested  	ingested  	 JJ	O
kava  	kava  	 JJ	O
products 	products 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
available  	available  	 JJ	O
oral  	oral  	 JJ	B-NP
toxicity  	toxicity  	 NN	I-NP
data  	data  	 NNS	I-NP
support  	support  	 VBP	O
the  	the  	 DT	O
concern  	concern  	 NN	O
about  	about  	 IN	O
liver  	liver  	 JJ	O
damage  	damage  	 NN	O
on  	on  	 IN	O
ingestion  	ingestion  	 NN	B-NP
but  	but  	 CC	O
do  	do  	 VBP	O
not  	not  	 RB	O
resolve  	resolve  	 VB	O
the  	the  	 DT	O
question 	question 	 NN	O
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
whether  	whether  	 IN	O
these  	these  	 DT	O
ingredients  	ingredients  	 NNS	O
would  	would  	 MD	O
be  	be  	 VB	O
substantially  	substantially  	 RB	O
absorbed  	absorbed  	 VBN	O
through  	through  	 IN	O
the  	the  	 DT	O
skin 	skin 	 NN	O
.  	.  	 .	O
Other  	Other  	 JJ	O
data  	data  	 NN	O
needs  	needs  	 NNS	O
are  	are  	 VBP	O
described 	described 	 VBN	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
toxicology  	toxicology  	 JJ	I-NP
data  	data  	 NNS	I-NP
for  	for  	 IN	I-NP
yangonin 	yangonin 	 NN	I-NP
,  	,  	 ,	O
methysticin 	methysticin 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
kavain 	kavain 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
present  	present  	 JJ	O
in  	in  	 IN	O
kava-derived  	kava-derived  	 JJ	O
ingredients 	ingredients 	 NNS	O
.  	.  	 .	O
Accordingly 	Accordingly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
available  	available  	 JJ	O
data  	data  	 NNS	O
are  	are  	 VBP	O
insufficient  	insufficient  	 JJ	O
to  	to  	 TO	O
support  	support  	 VB	O
the  	the  	 DT	O
safety  	safety  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
ingredients  	ingredients  	 NNS	O
in  	in  	 IN	O
cosmetics 	cosmetics 	 NNS	O
.  	.  	 .	O
